Results 51 to 60 of about 1,090 (156)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism

open access: yesFrontiers in Endocrinology, 2020
Background: A course of anti-thyroid drugs (ATD) is the most common first line treatment for Graves' hyperthyroidism. However, hyperthyroidism relapse is frequent (30–70%).
Rosario Le Moli   +7 more
doaj   +1 more source

The Relationship between Obesity-Related Factors and Graves’ Orbitopathy: A Pilot Study

open access: yesMedicina, 2022
Background and Objectives: The aim of this study was to investigate the relationships between obesity-related factors including body mass index (BMI), diabetes or prediabetes, hyperlipidemia, fasting plasma glucose, fasting plasma insulin, homeostasis ...
Ching Lu   +6 more
doaj   +1 more source

British Thyroid Association Survey of Graves' Disease Management in the UK

open access: yesClinical Endocrinology, Volume 103, Issue 3, Page 376-384, September 2025.
ABSTRACT Background Recent years have seen changes and uncertainties in evidence and guideline recommendations in Graves' disease treatment. To understand the impact of these developments on current practice, we undertook a survey of Graves' disease management in the United Kingdom and compared this to other national and international surveys.
Michael Atkinson   +5 more
wiley   +1 more source

Clinical Profile of Thyroid Eye Disease and Factors Predictive of Disease Severity in Chennai District of Tamil Nadu

open access: yesTNOA Journal of Ophthalmic Science and Research
Background: Thyroid eye disease (TED) is a possibly sightthreatening ocular disease generally occurring in the patients diagnosed with hyperthyroidism.
Mohamed Uwais Ulla   +3 more
doaj   +1 more source

Radiological Activity Score (RAS)—MRI Characteristics in Dysthyroid Optic Neuropathy in a Multi‐Ethnic Thyroid Eye Disease Population

open access: yesClinical Endocrinology, Volume 103, Issue 3, Page 385-395, September 2025.
ABSTRACT Purpose Dysthyroid Optic Neuropathy (DON) is a sight threatening and diagnostically challenging complication of Thyroid Eye Disease (TED). We provide a comparative analysis of the MRI features associated between patietnts with and without DON. Methods Anonymised retrospective cohort study of patients with TED over eleven years.
Malik Moledina   +11 more
wiley   +1 more source

Orbitopatía tiroidea: protocolo de manejo basado en revisión de la evidencia

open access: yesRevista Colombiana de Endocrinología, Diabetes y Metabolismo, 2019
La orbitopatía tiroidea es una patología potencialmente grave que amenaza la visión. Es la manifestación extratiroidea más frecuente de la enfermedad de Graves y, aunque la prevalencia no está evaluada en Colombia, puede producir pérdida de la visión ...
C. Gómez   +9 more
doaj   +1 more source

Resolution of Thyroid Acropachy in a Patient Treated With Teprotumumab: A Case Report and Review of Mechanisms

open access: yesCase Reports in Endocrinology, Volume 2025, Issue 1, 2025.
Graves’ disease is an autoimmune thyroidopathy associated with hyperthyroidism and nonendocrine manifestations such as thyroid eye disease (TED), pretibial myxedema, and thyroid acropachy. Thyroid acropachy is an uncommon but debilitating condition, typically characterized by digital clubbing, soft tissue swelling, and periosteal new bone formation in ...
Soumya Chatterjee, Toshihiro Kita
wiley   +1 more source

Thyroid Disorders and Serum Selenium Levels in a Southwestern Nigerian Population

open access: yesInternational Journal of Endocrinology, Volume 2025, Issue 1, 2025.
Background/Objective: Thyroid hormones are central to the regulation of energy expenditure and homoeostasis. An important microelement required for the optimal function of the thyroid gland is selenium. The question of whether Nigerian patients with thyroid disorders are deficient in selenium is what this study aims to answer.
Olufunmilayo Olubusola Adeleye   +5 more
wiley   +1 more source

Efficacy of rituximab in treating steroid-resistant Graves’ orbitopathy in active moderate-to-severe and sight-threatening forms: A retrospective observation from China

open access: yesHeliyon
Background and objectives: The efficacy of rituximab (RTX) in treating steroid-resistant Graves’ orbitopathy (GO) has been limitedly studied in Asians.
Ziyin Zhang   +7 more
doaj   +1 more source

Hypo vs. hyperthyroid eye disease: is there any difference?

open access: yesBMC Ophthalmology, 2023
Background Thyroid-eye disease (TED) is the most common extra-thyroidal presentation of graves’ disease. We performed this study to compare clinical characteristics of TED in hypothyroid vs. hyperthyroid patients.
Bahram Eshraghi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy